share_log

Canaccord Genuity Reiterates Buy on Enovis, Maintains $65 Price Target

Benzinga ·  Mar 28, 2023 07:48

Canaccord Genuity analyst Kyle Rose reiterates Enovis (NYSE:ENOV) with a Buy and maintains $65 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment